Literature DB >> 29802002

Rotavirus diarrhoea hospitalizations among children under 5 years of age in Nigeria, 2011-2016.

B N Tagbo1, J M Mwenda2, C B Eke3, B O Edelu3, C Chukwubuike4, G Armah5, M L Seheri6, A Isiaka7, L Namadi8, H U Okafor9, U C Ozumba4, R O Nnani10, V Okafor10, R Njoku11, C Odume12, C Benjamin-Pujah4, C Azubuike4, N Umezinne4, N Ogude10, V O Osarogborun10, M U Okwesili11, S K Ezebilo10, O Udemba11, K Yusuf8, Z Mahmud8, J M Ticha7, E O Obidike3, J M Mphahlele6.   

Abstract

BACKGROUND: The high burden of rotavirus acute gastroenteritis (AGE) is well documented among children under 5 years of age, with the majority of mortality occurring in developing countries. Nigeria ranked second worldwide in the number of rotavirus deaths in 2013. As Nigeria plans to introduce rotavirus vaccine soon, a pre-vaccine documentation of rotavirus disease burden is necessary to determine vaccine impact.
METHODS: Routine rotavirus surveillance was conducted during 2011-2016 in 3 sentinel sites in Nigeria using the standard WHO protocol. Children under 5 years of age hospitalized for acute gastroenteritis were enrolled and demographic, clinical and outcome data were collected. A stool sample was subsequently obtained and tested for human rotavirus antigen using the Enzyme-linked immunosorbent assay (ELISA).
RESULTS: 2694 children with acute gastroenteritis were enrolled during January 2011 to December 2016; of these, 1242 (46%) tested positive for rotavirus. Among the rotavirus positive cases, 66% and 94% were younger than 12 months and 24 months respectively. Marked peaks in rotavirus positivity were seen in January of each year. Vomiting, and use of oral and intravenous fluids occurred more often in rotavirus positive cases as compared to rotavirus negative cases.
CONCLUSION: The high prevalence of rotavirus disease highlights the need for urgent introduction of rotavirus vaccine in Nigeria. Additionally, this study provides pre-vaccine introduction disease-burden data that will serve as a baseline for rotavirus vaccine impact-assessment once vaccine has been introduced in the national immunization program.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Hospitalization; Nigeria; Risk factors; Rotavirus; Under 5 children; Vaccine

Mesh:

Substances:

Year:  2018        PMID: 29802002     DOI: 10.1016/j.vaccine.2018.03.084

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  The influence of demographic and meteorological factors on temporal patterns of rotavirus infection in Dhaka, Bangladesh.

Authors:  Ernest O Asare; Mohammad A Al-Mamun; Monira Sarmin; A S G Faruque; Tahmeed Ahmed; Virginia E Pitzer
Journal:  Proc Biol Sci       Date:  2022-06-08       Impact factor: 5.530

2.  Rotavirus breakthrough infections responsible for gastroenteritis in vaccinated infants who presented with acute diarrhoea at University Teaching Hospitals, Children's Hospital in 2016, in Lusaka Zambia.

Authors:  Julia Simwaka; Mapaseka Seheri; Gina Mulundu; Patrick Kaonga; Jason M Mwenda; Roma Chilengi; Evans Mpabalwani; Sody Munsaka
Journal:  PLoS One       Date:  2021-02-04       Impact factor: 3.240

3.  Epidemiology, diagnostics and factors associated with mortality during a cholera epidemic in Nigeria, October 2020-October 2021: a retrospective analysis of national surveillance data.

Authors:  Kelly Elimian; Sebastian Yennan; Anwar Musah; Iliya Danladi Cheshi; Carina King; Lauryn Dunkwu; Ahmed Ladan Mohammed; Eme Ekeng; Oluwatosin Wuraola Akande; Stephanie Ayres; Benjamin Gandi; Emmanuel Pembi; Fatima Saleh; Ahmed Nasir Omar; Emily Crawford; Olubunmi Omowumi Olopha; Robinson Nnaji; Basheer Muhammad; Rejoice Luka-Lawal; Adachioma Chinonso Ihueze; David Olatunji; Chidimma Ojukwu; Afolabi Muftau Akinpelu; Ene Adaga; Yusuf Abubakar; Ifeoma Nwadiuto; Samuel Ngishe; Agnes Bosede Alowooye; Peace Chinma Nwogwugwu; Khadeejah Kamaldeen; Henry Nweke Abah; Egbuna Hyacinth Chukwuebuka; Hakeem Abiola Yusuff; Ibrahim Mamadu; Abbas Aliyu Mohammed; Sarah Peter; Okpachi Christopher Abbah; Popoola Michael Oladotun; Santino Oifoh; Micheal Olugbile; Emmanuel Agogo; Nnaemeka Ndodo; Olajumoke Babatunde; Nwando Mba; John Oladejo; Elsie Ilori; Tobias Alfvén; Puja Myles; Chinwe Lucia Ochu; Chikwe Ihekweazu; Ifedayo Adetifa
Journal:  BMJ Open       Date:  2022-09-19       Impact factor: 3.006

4.  Rotavirus Genotypes in Hospitalized Children With Acute Gastroenteritis Before and After Rotavirus Vaccine Introduction in Blantyre, Malawi, 1997-2019.

Authors:  Chimwemwe Mhango; Jonathan J Mandolo; End Chinyama; Richard Wachepa; Oscar Kanjerwa; Chikondi Malamba-Banda; Prisca B Matambo; Kayla G Barnes; Chrispin Chaguza; Isaac T Shawa; Martin M Nyaga; Daniel Hungerford; Umesh D Parashar; Virginia E Pitzer; Arox W Kamng'ona; Miren Iturriza-Gomara; Nigel A Cunliffe; Khuzwayo C Jere
Journal:  J Infect Dis       Date:  2022-06-15       Impact factor: 7.759

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.